Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
27.4 EUR
1.86%
Market Closed
Updated:
Apr 27, 2024
Bayer AG
Research & Development
|
Bayer AG
Research & Development Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Research & Development
-€5.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Research & Development
-$62.2m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Research & Development
-€2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Research & Development
-€10.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Research & Development?
Research & Development
-5.4B
EUR
-5.4B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Research & Development amounts to -5.4B EUR.
What is Bayer AG's Research & Development growth rate?
Research & Development CAGR 10Y
-5%
-5%
Over the last year, the Research & Development growth was 18%. The average annual Research & Development growth rates for Bayer AG have been 9% over the past three years , -1% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
